Autosomal Dominant Polycystic Kidney Disease (ADPKD) is caused by the autosomal dominant transmission of mutations in one of two genes identified thus far: PKD1 (which accounts for about 85% of all cases and encodes for the polycystin-1 protein) and PKD2 (which accounts for about 15% of all cases and encodes for the polycystin-2 protein).
There are some commercially available services which will sequence the entirety of the PKD1 and PKD2 genes to search for mutations in order to help make a diagnosis of APKD in patients who are at risk (e.g., in younger patients born to a parent with ADPKD who therefore has a 50-50 chance of getting the gene but may not manifest a phenotype until they are older). However, such assays only pick up about 60-80% of mutations. This is mostly due to the genetic complexity of the PKD 1 gene: it is extremely large (46 exons), there are nearby pseudogenes with sequences that are highly homologous, and the gene is filled with polymorphisms (making it difficult to deterimine if a given sequence variant is pathogenic or not). However, the identification of specific mutations by genetic sequencing has been valuable in certain instances, such as if a young family member wishes to donate his/her kidney to a parent with ADPKD and wants to find out if they have inherited the family PKD mutation or not.
No comments:
Post a Comment
Renal Fellow Network encourages comments and discussion regarding the posts. Do not post any comments that are commercial or advertising in nature. Posts will be deleted if commercial or advertising comments are made. Internet users commenting on the Renal Fellow Network must post information which is true and correct to their knowledge. Sources to health/medical claims must be provided when relevant. Moderators reserve the right to erase, without notification, any comment they would judge inappropriate.